UCB Extraordinary General Meeting

UCB Extraordinary General Meeting

ID: 8071

(Thomson Reuters ONE) - Brussels, Belgium, 6 November, 2009 - 18:00 (CET) - regulatedinformation - Following the successful placement of its seniorunsecured convertible bonds, due 2015 (the 'Bonds') on 30 September2009, an extraordinary general shareholders' meeting was held earliertoday by the company.All proposed resolutions that were submitted to the extraordinarygeneral shareholders' meeting were approved, including allresolutions related to the recent bond issues and the appointment ofa new board member.For further informationRichard Simpson, Investor Relations, UCBT +32.2.559.9494, richard.simpson(at)ucb.comMichael Tuck-Sherman, Investor Relations, UCBT +32.2.559.9712, michael.tuck-sherman(at)ucb.comNancy Nackaerts, External Communications, UCBM: +32 473 86 44 14, nancy.nackaerts(at)ucb.comAbout UCBUCB, Brussels, Belgium (www.ucb.com) is a biopharmaceutical companydedicated to the research, development and commercialization ofinnovative medicines with a focus on the fields of central nervoussystem and immunology disorders. Employing approximately 10,000people in over 40 countries, UCB generated revenue of EUR 3.6 billionin 2008. UCB is listed on Euronext Brussels (symbol: UCB).Forward-looking statementsThis press release contains forward-looking statements based oncurrent plans, estimates and beliefs of management. Such statementsare subject to risks and uncertainties that may cause actual resultsto be materially different from those that may be implied by suchforward-looking statements contained in this press release. Importantfactors that could result in such differences include: changes ingeneral economic, business and competitive conditions, effects offuture judicial decisions, changes in regulation, exchange ratefluctuations and hiring and retention of its employees.For the pdf-version of this press release, please click on the linkbelow:http://hugin.info/133973/R/1353294/327778.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Komax shows impressive powers of innovation at the Productronica Opawica Announces Yukon Massive Sulphide Project Acquisition,
Completion of Financing, and New Presi
Bereitgestellt von Benutzer: hugin
Datum: 06.11.2009 - 18:00 Uhr
Sprache: Deutsch
News-ID 8071
Anzahl Zeichen: 0

contact information:
Town:

London



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 235 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"UCB Extraordinary General Meeting"
steht unter der journalistisch-redaktionellen Verantwortung von

UCB (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

UCB signs a new EUR 1.5 billion credit facility ...

Brussels, Belgium, December 15 2009 - 8:30 (CET). Regulated information. - UCB SA ("UCB" or the "Company") is pleased to announce the signing of its new EUR 1.5 billion revolving credit facility. The purpose of the facility is to ...

Alle Meldungen von UCB



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z